SC 13D Filing

Company

TENAX THERAPEUTICS, INC.

Filed

July 16, 2020

Accession Number

0000919574-20-004612

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →